World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
82
Citations
28717
World Ranking
1488
National Ranking
749

Medicine

D-Index
83
Citations
29517
World Ranking
15481
National Ranking
7808

Evan M. Hersh publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Evan M. Hersh sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 522 publications — 91st percentile

91% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Evan M. Hersh D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Evan M. Hersh sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 82 D-Index — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Evan M. Hersh was affiliated with The University of Texas MD Anderson Cancer Center in the United States during their academic career. Their work was situated within a leading cancer research institution, contributing to the scientific community through their involvement in this prominent center.

Although specific details about their fields of study, subfields, main topics of work, and publication record are not available, the association with MD Anderson Cancer Center suggests a focus likely related to cancer research or oncology. No records of recent papers, frequent co-authors, or recurring publication venues were provided to outline further details of their research contributions.

There are no records of book publications or awards linked to Evan M. Hersh. The absence of these data points means there are no documented recognitions or extended authorship contributions such as monographs or edited volumes known from this profile.

Given that Evan M. Hersh is deceased, all references to their work and affiliations are presented in past tense consistent with standard biographical conventions. Their contributions remain part of the academic fabric, although specific publication and research details have not been cataloged in the provided data.

Best Publications

  • A new type of synthetic peptide library for identifying ligand-binding activity

    Kit S. Lam;Sydney E. Salmon;Evan M. Hersh;Victor J. Hruby

  • Non-Hodgkin's Lymphoma in 90 Homosexual Men: Relation to Generalized Lymphadenopathy and the Acquired Immunodeficiency Syndrome

    John L. Ziegler;Jay A. Beckstead;Paul A. Volberding;Donald I. Abrams

  • Alpha Interferon for Induction of Remission in Hairy-Cell Leukemia

    Jorge R. Quesada;James M Reuben;John T. Manning;Evan M. Hersh

  • Leukocyte Interferon-Induced Tumor Regression in Human Metastatic Breast Cancer, Multiple Myeloma, and Malignant Lymphoma

    Jordan U. Gutterman;George R. Blumenschein;Raymond Alexanian;Hwee-Yong Yap

  • Bcl-2 Antisense (oblimersen sodium) Plus Dacarbazine in Patients With Advanced Melanoma: The Oblimersen Melanoma Study Group

    Agop Y. Bedikian;Michael Millward;Hubert Pehamberger;Robert Conry

  • Phase I/II study of ipilimumab for patients with metastatic melanoma

    Jeffrey S. Weber;Steven O’Day;Walter Urba;John Powderly

  • Liposomal Amphotericin B for the Treatment of Systemic Fungal Infections in Patients with Cancer: A Preliminary Study

    Gabriel Lopez-Berestein;Victor Fainstein;Roy Hopfer;Kapil Mehta

  • Impaired in vitro lymphocyte transformation in Hodgkin's disease.

    Evan M. Hersh;Joost J. Oppenheim

  • Local drug and gene delivery through microbubbles

    Evan C Unger;Evan Hersh;Mani Vannan;Terry O Matsunaga

  • A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma.

    Evan M. Hersh;Steven J. O’Day;John Powderly;Khuda D. Khan

  • Phase I and pharmacokinetics trial of ABI-007, a novel nanoparticle formulation of paclitaxel in patients with advanced nonhematologic malignancies.

    David W. Nyman;Kimberley J. Campbell;Evan Hersh;Kristen Long

  • Treatment and Prophylaxis of Disseminated Infection Due to Candida albicans in Mice with Liposome-Encapsulated Amphotericin B

    G. Lopez-Berestein;R. Mehta;R. L. Hopfer;K. Mills

  • Chemotherapy, Immunocompetence, Immunosuppression and Prognosis in Acute Leukemia

    Evan M. Hersh;John P. Whitecar;Kenneth B. Mccredie;Gerald P. Bodey

  • Cells Capable of Colony Formation in the Peripheral Blood of Man

    Kenneth B. McCredie;Evan M. Hersh;Emil J Freireich

  • Macrophage-Lymphocyte Interaction in the Antigen-Induced Blastogenic Response of Human Peripheral Blood Leukocytes

    Evan M. Hersh;Jules E. Harris

  • Treatment of hairy cell leukemia with recombinant alpha-interferon.

    JR Quesada;EM Hersh;J Manning;J Reuben

  • Double-Blind Randomized Phase II Study of the Combination of Sorafenib and Dacarbazine in Patients With Advanced Melanoma : A Report From the 11715 Study Group

    David F. McDermott;Jeffrey A. Sosman;Rene Gonzalez;F. Stephen Hodi

  • The Transformation of Column-Purified Lymphocytes with Nonspecific and Specific Antigenic Stimuli

    Joost J. Oppenheim;Brigid G. Leventhal;Evan M. Hersh

  • ACTIVE IMMUNOTHERAPY WITH B.C.G. FOR RECURRENT MALIGNANT MELANOMA

    J.U Gutterman;C McBride;E.J Freireich;G Mavligit

  • Pharmacokinetics of recombinant interleukin 2 in humans.

    Michael W. Konrad;George Hemstreet;Evan M. Hersh;Peter W. A. Mansell

Frequent Co-Authors

Jordan U. Gutterman
Jordan U. Gutterman The University of Texas MD Anderson Cancer Center
James M. Reuben
James M. Reuben The University of Texas MD Anderson Cancer Center
Roger D. Rossen
Roger D. Rossen Baylor College of Medicine
Gabriel N. Hortobagyi
Gabriel N. Hortobagyi The University of Texas MD Anderson Cancer Center
Gerald P. Bodey
Gerald P. Bodey The University of Texas MD Anderson Cancer Center
Steven J. O'Day
Steven J. O'Day St. John's University
Kapil Mehta
Kapil Mehta MolQ Laboratory
George R. Blumenschein
George R. Blumenschein The University of Texas MD Anderson Cancer Center
Jeffrey S. Weber
Jeffrey S. Weber New York University
Emil J. Freireich
Emil J. Freireich The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related healthcare degrees can provide diverse career opportunities. Nursing pathways, for example, often complement immunological knowledge, especially in specialized fields like psychiatric or acute care. If you're considering advancing in nursing, programs such as the cheapest pmhnp programs offer accessible ways to specialize in psychiatric mental health as a nurse practitioner.

Additionally, transitioning within nursing specialties is a common pathway. For example, nurses aiming to shift from family practice to acute care might find guidance through resources on fnp to acnp career moves, allowing for expanded clinical expertise relevant to immunology-related patient care.

Accelerated study options also exist for those seeking quicker certification. Accelerated fnp programs enable students to fast-track their education while keeping clinical immunology insights in focus.

Finally, understanding the financial outlook is crucial. Many advanced degrees, including a doctorate in nursing salary statistics, reveal strong earning potential, making further education in immunology-adjacent careers a wise investment.

Best Scientists Citing Evan M. Hersh

Recently Published Articles